Abstract. B cell-deficient C57Bl/6 (MT) mice were resistant to Leishmania major after both primary and secondary parasite challenge. However, unlike in wild-type mice, secondary infection in MT mice was not accompanied by a marked delayed type hypersensitivity-like response, and interferon-␥ (IFN-␥) levels were approximately half of those in wild-type mice. These results suggest that B cells are involved in IFN-␥ production and the pathology of secondary infection.
In addition to these studies, the finding that primary resistance does not require antibodies to L. major supports the minimal role conclusion for B cells. 2, 10, 11 Recent studies have shown that the importance of B cells in primary and secondary responses to intracellular pathogens can differ. In both wild-type and MT mice, primary infection with the intracellular bacterial parasite Chlamydia tracomatis leads to immunologic resistance. 12, 13 However, in contrast to wild-type mice, resistance to a secondary challenge is reduced or absent in MT mice. 12, 13 Interestingly, both interferon-␥ (IFN-␥) production and delayed type hypersensitivity (DTH) responses are also reduced following secondary challenge in MT mice. 13 Reduction of IFN-␥ production in B celldeficient mice, relative to wild-type mice, has also been reported following infection with Listeria monocytogenes or Neospora caninum. 14, 15 Both DTH responses and IFN-␥ production are closely associated with resistance to L. major, and the development of Th1 responses correlates with the ability to develop DTH responses to Leishmania antigens. 3, 4, 9, 16, 17 Although it is evident that the absence of B cells does not alter resistance to L. major following primary infection, 7−9 the question addressed here was how do B cells influence the recall response to L. major.
Wild-type C57Bl/6 and MT mice were originally obtained from Jackson Laboratories (Bar Harbor, ME) and bred at the Laboratory Animal Resources facility at Colorado State University as previously described. 18 The maintenance and care of all experimental animals complied with National Institutes of Health guidelines for the humane use of laboratory animals. Female mice (6−8 weeks of age, five per group) were infected with 10 6 L. major promastigotes (LV39, RHO/SU/ 59/P, Neal, or P strain) in one rear foot pad. 19 Lesion size was monitored over time with vernier calipers (lesion size ‫ס‬ infected foot -contralateral uninfected foot).
As shown in Figure 1A , we confirmed that both wild-type and MT mice were resistant to L. major after primary challenge. However, using an enzyme-linked immunosorbent assay technique 20 to analyze 48-hour supernatants from cultured, L. major-restimulated lesion-draining lymph node cells taken 20 days post-infection, we observed that cells from MT mice produced significantly less IFN-␥ (approximately half as much; P ‫ס‬ 0.01) than did cells from wild-type mice (Table 1) . These data are similar to those of others who showed reduced IFN-␥ production after pathogen challenge in MT mice. 13−15 In contrast, we found that production of interleukin-2 (IL-2), IL-4, and IL-10 was not different between the two mouse strains. Interestingly, Brown and Reiner 7 found no difference in IFN-␥ mRNA levels between wild-type and MT mice infected with L. major, but they analyzed CD4 + lesion-draining lymph node cells only, rather than production by all lymph node cells as described here. A study by Harris and others 21 has shown that some B cells can produce IFN-␥. Therefore, it is possible that the reduced IFN-␥ production observed here for MT mice was due to the lack of B cell-produced IFN-␥. To examine if a similar phenomenon was occurring in the lesion itself, mRNA levels for IFN-␥ were measured in lesions from wild-type and MT mice 21 days post-infection using a reverse transcription−polymerase chain reaction technique as described previously. 19 The data from three individual animals per group are shown in Table 1 (presented as the relative ratio of mRNA for IFN-␥/␤-actin) and indicate that IFN-␥ mRNA levels were lower by 42% in MT mice relative to wild-type mice. This reduction in lesion IFN-␥ mRNA was approximately the same magnitude as the reduction in IFN-␥ protein produced by lymph node cells from MT mice.
After lesion resolution (approximately 70 days), some mice (2−4 per group) were reinfected with 10 6 L. major in the contralateral uninfected footpad. As shown in Figure 1B , an increase in lesion size indicative of a DTH response was observed in wild-type mice and was typical for secondary exposures to L. major antigens. 8 The peak of this response occurred on day three after rechallenge, and lesion resolution was complete by approximately day 40. In contrast, in MT mice, little or no increase in lesion size was observed after secondary infection, and only small lesions were observed to develop in any of these mice in two separate experiments.
Importantly, all lesions resolved in MT mice over the same time frame as observed for wild-type mice, and no difference in parasite burdens was found. Thus, a lack of B cells did not alter resistance to L. major after secondary challenge. Because DTH responses are associated with IFN-␥ production in L. major-infected animals, 3, 4, 9, 16, 17 IFN-␥ mRNA levels were measured in lesions taken three days after reinfection with parasites. As shown in Table 1 , IFN-␥ mRNA levels were reduced by 47% on average in two experiments (the lesions from two animals were pooled per group in each experiment). Clearly, although reduced in the absence of B cells, the amount of IFN-␥ was sufficient to facilitate resistance in MT mice. It is unclear, however, if the lack of a DTH response was the result of reduced IFN-␥ expression or if they are merely coexpressed phenomena. It is interesting that Babai and others 8 found that in B-1 cell-depleted mice, the DTH response to L. major antigen was unchanged, relative to wild-type mice, nine weeks after primary challenge 
